LY 307452

Discontinued Product

1474 has been discontinued.

View all Glutamate (Metabotropic) Group II Receptors products.
说明: Selective group II mGlu antagonist
化学名: (4S)-4-(4,4-Diphenylbutyl)-L-glutamic acid
说明书
引用文献
评论
文献 (4)

生物活性 for LY 307452

Selective and competitive group II metabotropic glutamate receptor antagonist. Centrally active following systemic administration in vivo.

许可信息

Sold with the permission of Eli Lilly and Company.

技术数据 for LY 307452

分子量 355.43
储存 Desiccate at +4°C
CAS Number 174393-13-6

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书 for LY 307452

分析证书目前不在网上提供。
请联系客户服务

关键词: LY 307452, LY 307452 supplier, Glutamate, (Metabotropic), Group, II, Receptors, 1474, Tocris Bioscience

篇 LY 307452 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 LY 307452 的引用文献。

LY 307452 的评论

目前没有该产品的评论。 Be the first to review LY 307452 and earn rewards!

Have you used LY 307452?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Metabotropic Glutamate Receptors Scientific Review

Metabotropic Glutamate Receptors Scientific Review

Written by Francine Acher, this review discusses the pharmacology and therapeutic potential of mGlu receptors, and the compounds acting upon them; compounds available from Tocris are listed.

Addiction Poster

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.